#NoGoingBack is a wonderful and sorely needed initiative. The idea is to "preserve the progress we've made in clinical research". For some this will be a no-brainer; for others, sustaining change over time, or after the urgency lessens, will be hard. If you need help, contact us!
Technology is already in our hands to better employ Remote Monitoring for today's clinical trials. Read about at Recent Columns at https://t.co/O79WO84xk3 #remotemonitoring#ClinicalResearch#clinicaltrials
#Coronavirus testing must be made free to the public if we are going to understand the scope of this crisis.
Anything less will undermine America’s effort to protect our communities and save lives.
RT if you agree #FamiliesFirst
Pleased to announce Waife & Associates is now part of the WCG family of companies providing high unique value to the clinical research process. #waife#wcg
Pharma development needs to heed Mark Twain: “Progressive improvement beats delayed perfection”. Our progress to clinical development innovation is stopped by the churning for consensus, not by a lack of tools or resources. See our latest blog post @WaifeAssoc
"Virtual trials"? Let's work on something more real: decentralized trials. And AI making simulated trials? Not very patient-centric! Let's do real trials more efficiently. For more, read latest column at https://t.co/O79WO7MVVt
In the Clinical stage of drug development, we can't change the Science but we can improve the processes and infrastructure. Prioritize what you can control to improve speed, compliance and productivity.
Can we move Clinical Data Management from an atmosphere of FUD (fear, uncertainty and doubt)about our data to CCT (confidence, certainty and trust)? We can with the correct updated processes, and appropriately skilled personnel, and W&A can help. #CDM#clinicaltrials
Let’s “outsource” clinical trial ops to the struggling underemployed in our own countries. I first talked about this more than 12 years ago. See inspiring Sunday NY Times article titled “Silicon Holler” by Arlie Hochschild. Let’s organize equivalent training for our needs!
Announcing our new Video Series! Commentary on clinical research technologies, methods and use of consulting firms. Find them on YouTube or https://t.co/rrciULeJK4.
5th Annual Waife Scholarship in Scientific Journalism awarded to Needham HS graduate Alex Partridge. Scholarship promotes professionalism in science writing, in honor of Benjamin & Sholom Waife. Read more at https://t.co/O79WO84xk3
Biopharma culture protects a lack of urgency – the one thing we really need. Mergers and acquisitions make it worse. One-off change efforts are not enough to fix it. Read more at https://t.co/O79WO84xk3
Another reason to come to Boston June 24-26! Come meet privately with Waife & Associates at our hotel suite near the Convention Center. We are scheduling one-to-one free consultations on the Clinical Operations topic of your choice. Reserve your slot - email [email protected].
Why do we continue to struggle with Clinical Trial Transparency? A robust and optimal compliance solution is remarkably complex and resource-intensive, but requires only will and funding. Read more at https://t.co/O79WO84xk3
Is new information technology always the answer to a clinical trial operations problem? Should you spend more time on why and how you would use it?. Read more at https://t.co/O79WO84xk3
Too many overlapping process improvement projects can make competing demands on key staff’s time. Prioritizing can be paralyzed by politics. Use W&A to rationalize and maximize your PI investments. Contact [email protected]
Your vendor oversight probably needs improving. The CRO industry has grown to many billions of dollars per year, but its biopharma customers have done so little to prepare themselves to manage their activities. Contact [email protected] or [email protected] on how we can help.